Surgical Science Sweden AB - Asset Resilience Ratio
Surgical Science Sweden AB (SUS) has an Asset Resilience Ratio of 12.32% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Surgical Science Sweden AB debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2022)
This chart shows how Surgical Science Sweden AB's Asset Resilience Ratio has changed over time. See Surgical Science Sweden AB (SUS) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Surgical Science Sweden AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Surgical Science Sweden AB worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr606.06 Million | 12.32% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr606.06 Million | 12.32% |
Asset Resilience Insights
- Moderate Liquidity: Surgical Science Sweden AB has 12.32% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Surgical Science Sweden AB Industry Peers by Asset Resilience Ratio
Compare Surgical Science Sweden AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Longmaster Information Tech
SHE:300288 |
Health Information Services | 0.68% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 48.49% |
|
Pharmx Technologies Ltd
AU:PHX |
Health Information Services | 22.16% |
|
Intelicare Holdings Ltd
AU:ICR |
Health Information Services | 64.05% |
|
Global Health Ltd
AU:GLH |
Health Information Services | 9.84% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
Annual Asset Resilience Ratio for Surgical Science Sweden AB (2016–2022)
The table below shows the annual Asset Resilience Ratio data for Surgical Science Sweden AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 9.33% | Skr433.73 Million ≈ $46.68 Million |
Skr4.65 Billion ≈ $500.37 Million |
+1.37pp |
| 2021-12-31 | 7.96% | Skr316.68 Million ≈ $34.08 Million |
Skr3.98 Billion ≈ $428.11 Million |
-10.49pp |
| 2020-12-31 | 18.45% | Skr87.16 Million ≈ $9.38 Million |
Skr472.27 Million ≈ $50.82 Million |
+3.28pp |
| 2019-12-31 | 15.17% | Skr69.22 Million ≈ $7.45 Million |
Skr456.21 Million ≈ $49.10 Million |
-23.46pp |
| 2018-12-31 | 38.63% | Skr38.50 Million ≈ $4.14 Million |
Skr99.66 Million ≈ $10.72 Million |
-0.33pp |
| 2017-12-31 | 38.96% | Skr38.54 Million ≈ $4.15 Million |
Skr98.92 Million ≈ $10.65 Million |
+33.04pp |
| 2016-12-31 | 5.91% | Skr3.77 Million ≈ $405.46K |
Skr63.70 Million ≈ $6.86 Million |
-- |
About Surgical Science Sweden AB
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator … Read more